News Latest Sep 25, 2025 Theratechnologies Announces Completion of Acquisition by Future Pak Press Releases Year None20252024 Oct 17, 2024 Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV Oct 17, 2024 Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance Oct 10, 2024 Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024 Oct 09, 2024 Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV Sep 26, 2024 Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update Sep 17, 2024 Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025 Sep 09, 2024 Theratechnologies to Present at Upcoming Investor Conferences in September Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024 Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors First page « Previous page ‹ Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Next page › Last page » Displaying 31 - 40 of 61
Oct 17, 2024 Theratechnologies IDWeek Presentations Highlight the Impact of Excess Visceral Abdominal Fat (EVAF) on Cardiovascular Disease (CVD) Risk in People with HIV
Oct 17, 2024 Theratechnologies Unveils Study Design and Baseline Characteristics of PROMISE-US Trial of Ibalizumab in Heavily Treatment-Experienced People with HIV and Multidrug Resistance
Oct 10, 2024 Theratechnologies Reports Strong Financial Results and Announces Positive Net Income for Third Quarter 2024
Oct 09, 2024 Theratechnologies to Present Data at IDWeek 2024 Highlighting Advances in Treatment and Management of Complications in People with HIV
Sep 26, 2024 Theratechnologies to Announce Third Quarter 2024 Financial Results and Provide Business Update
Sep 17, 2024 Theratechnologies Announces a Risk of a Temporary Supply Disruption for EGRIFTA SV® in Early 2025
Jul 10, 2024 Theratechnologies Reports Financial Results and Announces Positive Net Income for Second Quarter 2024
Jun 26, 2024 Theratechnologies to Announce Second Quarter 2024 Financial Results and Provide Business Update
May 23, 2024 Theratechnologies’ Sudocetaxel Zendusortide ASCO 2024 Presentation Demonstrates Signs of Long-Term Efficacy and Manageable Safety Profile in Patients with Solid Tumors
